# Clinical trials recruiting in Georgia: 160 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 160 trials recruiting or not yet recruiting with a site in Georgia, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Georgia: 160 rows for $8, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 3 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/country/georgia

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 160
- Recruiting or not yet: 160
- Read on: November 19, 2026

## Trials

The 25 newest of 160, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 3, 2026 | NCT07911800 | rhTPO for Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Procedures. | MIBIO PTE. LTD. | Phase 3 | Recruiting | Thrombocytopenia Associated With Chronic Liver Disease | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07911800) |
| October 21, 2026 | NCT07885891 | Cefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia | Wockhardt | Phase 3 | Not yet recruiting | Hospital Acquired Bacterial Pneumonia (HABP), Ventilator Associated Bacterial Pneumonia (VABP) | 324 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07885891) |
| October 16, 2026 | NCT07877051 | A Clinical Study of the Aqua Therapeutics Thermal Therapy Vapor Ablation System in Premenopausal Women With Abnormal Uterine Bleeding | Aqua Therapeutics, Inc. | Not applicable | Recruiting | Menorrhagia | 43 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07877051) |
| October 5, 2026 | NCT07858643 | A Study of LDGraft In Single Level Lumbar Interbody Fusion | Locate Bio Ltd | Phase 1/2 | Recruiting | Degenerative Disc Disease Lumbar | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07858643) |
| October 1, 2026 | NCT07851025 | Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced... | AstraZeneca | Phase 3 | Recruiting | Epithelial Ovarian Cancer | 950 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07851025) |
| September 29, 2026 | NCT07845487 | A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis | Sponsor not shown (see the record) | Phase 2 | Recruiting | Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis | 204 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07845487) |
| September 9, 2026 | NCT07810335 | Evaluation of FlowMod System While Intermittently Partially Occluding Vena Cava Blood Flow in Subjects With ADHF | FlowMod, Inc. | Not applicable | Not yet recruiting | Acute Decompensated Heart Failure (ADHF) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07810335) |
| September 1, 2026 | NCT07796659 | EXPLORE MRace (GE): Early Feasibility Experience of Posterior Leaflet Restoration to Reduce Mitral Regurgitation Using the MRace Implant | Polares Medical SA | Not applicable | Recruiting | Mitral Valve Disease | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07796659) |
| August 21, 2026 | NCT07779616 | Study of PTC844 in Participants With Active Rheumatoid Arthritis | PTC Therapeutics | Phase 2 | Recruiting | Rheumatoid Arthritis | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07779616) |
| August 13, 2026 | NCT07762027 | A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Participants With Chronic Hepatitis D Virus Infection | Assembly Biosciences | Phase 2 | Not yet recruiting | Chronic Hepatitis D Infection | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07762027) |
| July 15, 2026 | NCT07704099 | Safety and Efficacy of KER-065 in Participants With Duchenne Muscular Dystrophy | Keros Therapeutics, Inc. | Phase 2 | Recruiting | Duchenne Muscular Dystrophy | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07704099) |
| July 13, 2026 | NCT07697599 | Venous Thromboembolism (VTE) Prophylaxis With REGN7508 and REGN9933 in Adult and Adolescent Participants With a Peripherally Inserted... | Regeneron Pharmaceuticals | Phase 3 | Recruiting | Venous Thromboembolism (VTE) | 1,908 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07697599) |
| July 6, 2026 | NCT07684820 | To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment | Expedition Therapeutics, Inc | Phase 2 | Recruiting | Chronic Obstructive Pulmonary Disease (COPD) | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07684820) |
| June 15, 2026 | NCT07647510 | A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE) | Dianthus Therapeutics | Phase 3 | Recruiting | Myasthenia Gravis, Generalized | 195 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07647510) |
| June 4, 2026 | NCT07627022 | Impact of a Reminder App on Physical Activity During Radiation Therapy for Lung Cancer | University Hospital Schleswig-Holstein | Not applicable | Not yet recruiting | Lung Cancer | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07627022) |
| June 4, 2026 | NCT07625644 | BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01) | SystImmune Inc. | Phase 3 | Recruiting | Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer, Small Cell Carcinoma, Sclc, SCLC,Extensive Stage, Lung... | 550 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07625644) |
| June 3, 2026 | NCT07623200 | A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia | Incyte Corporation | Phase 3 | Recruiting | Essential Thrombocythemia | 426 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07623200) |
| May 28, 2026 | NCT07610564 | A Study to Assess the Effect of Empasiprubart on Nerve Morphology by Ultrasound in Adults With Multifocal Motor Neuropathy | argenx | Phase 1 | Recruiting | Multifocal Motor Neuropathy (MMN) | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07610564) |
| May 20, 2026 | NCT07598760 | Clinical Feasibility of Cardiac Neuromodulation Therapy for Heart Failure With Preserved Ejection Fraction | BackBeat Medical Inc | Not applicable | Not yet recruiting | Hypertension (HTN), Heart Failure With Preserved Ejection Fraction (HFpEF, Hypertension, Systolic | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07598760) |
| May 19, 2026 | NCT07596849 | A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease. | argenx | Phase 3 | Recruiting | Graves Disease | 230 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07596849) |
| May 6, 2026 | NCT07570316 | A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease | argenx | Phase 3 | Recruiting | Graves' Disease, Graves Disease | 230 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07570316) |
| May 1, 2026 | NCT07562152 | Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma | Immuneering Corporation | Phase 3 | Recruiting | Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal... | 570 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07562152) |
| April 20, 2026 | NCT07540572 | A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid... | IDEAYA Biosciences | Phase 1 | Recruiting | Cancer | 155 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07540572) |
| April 16, 2026 | NCT07533955 | A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis | Jade Biosciences, Inc. | Phase 1 | Recruiting | Rhematoid Arthritis | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07533955) |
| April 13, 2026 | NCT07522073 | A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal... | Incyte Corporation | Phase 3 | Recruiting | Solid Tumors | 588 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07522073) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Tbilisi Heart and Vascular Clinic | Tbilisi | 10 |
| Caucasus Medical Centre | Tbilisi | 9 |
| LEPL The First University Clinic of Tbilisi State Medical University | Tbilisi | 7 |
| LTD High Technology Hospital Medcenter | Batumi | 7 |
| New Hospitals | Tbilisi | 7 |
| Tbilisi Heart Center | Tbilisi | 6 |
| LLC Todua Clinic | Tbilisi | 6 |
| Pineo Medical Ecosystem | Tbilisi | 4 |
| JSC K. Eristavi National Center of Experimental and Clinical Surgery | Tbilisi | 4 |
| Tbilisi Heart and Vascular Center | Tbilisi | 3 |
| LTD Israeli-Georgian Medical Research Clinic Healthycore | Tbilisi | 3 |
| Multiprofile Clinic Consilium Medulla | Tbilisi | 3 |
| LTD The First Medical Center | Tbilisi | 3 |
| Israeli-Georgian Medical Research Clinic Healthycore | Tbilisi | 3 |
| LTD "New Hospitals" | Tbilisi | 3 |
| Institute of Clinical Oncology | Tbilisi | 3 |
| LTD "Israeli-Georgian Medical Research Clinic Healthycore" | Tbilisi | 3 |
| Ltd New Hospitals | Tbilisi | 3 |
| American Hospital Network LLC | Tbilisi | 3 |
| High Technology Hospital Medcenter LTD | Batumi | 2 |
| K. Eristavi National Center of Experimental and Clinical Surgery | Tbilisi | 2 |
| LTD Todua Clinic | Tbilisi | 2 |
| Ltd "Health" | Batumi | 2 |
| Israeli - Georgian Medical Research Clinic Healthycore LTD | Tbilisi | 2 |
| High Technology Hospital Medcenter | Batumi | 2 |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 23 |
| Phase 1/2 | 10 |
| Phase 2 | 23 |
| Phase 2/3 | 8 |
| Phase 3 | 64 |
| Not applicable | 27 |
| Observational | 5 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Heart Failure | 10 |
| Colitis, Ulcerative | 9 |
| Carcinoma, Non-Small-Cell Lung | 9 |
| Myasthenia Gravis | 6 |
| Arthritis, Rheumatoid | 6 |
| Crohn Disease | 6 |
| Lupus Erythematosus, Systemic | 5 |
| Inflammatory Bowel Diseases | 5 |
| Colorectal Neoplasms | 5 |
| Breast Neoplasms | 4 |
| Mitral Valve Insufficiency | 4 |
| Endometrial Neoplasms | 4 |
| Graves Disease | 4 |
| Small Cell Lung Carcinoma | 4 |
| Stomach Neoplasms | 4 |
| Pancreatic Neoplasms | 3 |
| Pulmonary Disease, Chronic Obstructive | 3 |
| Autoimmune Diseases | 3 |
| Fallopian Tube Neoplasms | 3 |
| Neoplasms | 3 |
| Neoplasm Metastasis | 3 |
| Liver Diseases | 3 |
| Lung Neoplasms | 3 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
| Colitis | 2 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 10 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 6 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 5 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 5 |
| [argenx](https://specstream.ai/data/clinical-trials/company/argenx) | 4 |
| [BioNTech SE](https://specstream.ai/data/clinical-trials/company/biontech-se) | 3 |
| [Incyte Corporation](https://specstream.ai/data/clinical-trials/company/incyte-corporation) | 3 |
| Immunovant Sciences GmbH | 3 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 3 |
| Climb Bio, Inc. | 2 |
| [UCB Biopharma SRL](https://specstream.ai/data/clinical-trials/company/ucb-biopharma-srl) | 2 |
| Axon Therapies, Inc. | 2 |
| [Xencor, Inc.](https://specstream.ai/data/clinical-trials/company/xencor-inc) | 2 |
| IDEAYA Biosciences | 2 |
| SystImmune Inc. | 2 |
| [Arrowhead Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/arrowhead-pharmaceuticals) | 2 |
| Dianthus Therapeutics | 2 |
| Alleviant Medical, Inc. | 2 |
| Zenas BioPharma (USA), LLC | 2 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 2 |
| Kartos Therapeutics, Inc. | 2 |
| [Insmed Incorporated](https://specstream.ai/data/clinical-trials/company/insmed-incorporated) | 2 |
| [Shanghai Henlius Biotech](https://specstream.ai/data/clinical-trials/company/shanghai-henlius-biotech) | 2 |
| [Octapharma](https://specstream.ai/data/clinical-trials/company/octapharma) | 1 |
| Davinci LTD | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Georgia

- [Steakhouses in Georgia, United States](https://specstream.ai/data/businesses/steakhouses/georgia-united-states)
- [Hospices in Georgia, United States](https://specstream.ai/data/businesses/hospices/georgia-united-states)
- [Assisted living facilities in Georgia, United States](https://specstream.ai/data/businesses/assisted-living-facilities/georgia-united-states)
- [Naturopathic clinics in Georgia, United States](https://specstream.ai/data/businesses/naturopathic-clinics/georgia-united-states)
- [Cooking schools in Georgia, United States](https://specstream.ai/data/businesses/cooking-schools/georgia-united-states)
- [Salvadoran restaurants in Georgia, United States](https://specstream.ai/data/businesses/salvadoran-restaurants/georgia-united-states)
